Back

Influence of obesity on the safety and efficacy of antithrombotic therapy: a systematic review and meta-analysis

26 August 2022 (13:15 - 14:00)
Organised by:
Congress Presentation Part of: Challenges and advances in antithrombotic therapy Anticoagulants ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Beatriz Rocha Darze

Bahiana School of Medicine and Public Health, Salvador (Brazil)

6 More presentations in this session

Presentation thumbnail
A randomized, cross-over study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of milvexian with single and dual antiplatelet therapy in healthy participants
Doctor G. Abelian (US)
Abstract Slides
Presentation thumbnail
Effect of low-dose rivaroxaban with low-dose aspirin vs low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease
Associate Professor B. Rocca (Casamassima, IT)
Abstract Slides
Presentation thumbnail
Antithrombotic strategies in antiphospholipid syndrome with arterial thrombosis: a systematic review and network meta-analysis
Doctor T. Attachaipanich (Chiang Mai, TH)
Abstract Slides
Presentation thumbnail
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Doctor K. Matli (Paris, FR)
Abstract Slides
Presentation thumbnail
CS014 is a novel HDAC inhibitor regulating the platelet activity, fibrinolysis and clot stability for prevention of thrombosis without increased risk of bleeding
Associate Professor M. Holinstat (Ann Arbor, US)
Abstract Slides

Access the full session

Session thumbnail
Challenges and advances in antithrombotic therapy

The Event

Event poster

ESC Congress 2022

26 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of direct oral anticoagulants versus warfarin in obese patients: a systematic review and meta-analysis of 31 studies
26 April 2024
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
ST-elevated myocardial infarction and the obesity paradox
22 May 2023
thumbnail
Congress Presentation
The impact of body mass on cardiovascular outcomes in patients with acute coronary syndrome
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources